resveratrol has been researched along with Mitochondrial Diseases in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 5 (31.25) | 2.80 |
| Authors | Studies |
|---|---|
| Laforêt, P; Løkken, N; Madsen, KL; Nadaj-Pakleza, A; Storgaard, JH; Tard, C; van Hall, G; Vissing, J; Voermans, NC; Ørngreen, MC | 1 |
| Decheng, B; Lixia, Z; Wei, S | 1 |
| Baartscheer, A; Bezzina, CR; Bleeker, JC; Coronel, R; Ferdinandusse, S; Guan, K; Houtkooper, RH; IJlst, L; Knottnerus, SJG; Li, W; Luo, X; Mengarelli, I; Portero, VM; Ulbricht, Y; Verkerk, AO; Visser, G; Wanders, RJA; Wijburg, FA; Wüst, RCI | 1 |
| Chen, Y; Ji, S; Jia, P; Li, Y; Wang, T; Xu, J; Zhang, H | 1 |
| Chen, KG; Deng, Y; Kang, RR; Liu, C; Liu, K; Liu, W; Ma, Z; Sun, Q; Xu, B | 1 |
| Borges, F; Chavarria, D; Karkucinska-Wieckowska, A; Oliveira, PJ; Teixeira, J; Wieckowski, MR; Wojtczak, L | 1 |
| De Paepe, B; Van Coster, R | 1 |
| Feng, Y; Niu, W; Wang, J; Wang, Y; Xiang, D; Yuan, F; Zhang, X | 1 |
| Komen, JC; Thorburn, DR | 1 |
| Valero, T | 1 |
| Bastin, J; Djouadi, F; Le Bachelier, C; Lebre, AS; Lopes Costa, A; Mathieu, L; Slama, A; Taylor, RW | 1 |
| Anton, SD; Bernabei, R; Carter, CS; Leeuwenburgh, C; Marzetti, E; Wohlgemuth, SE | 1 |
| Koopman, WJ; Manjeri, GR; Rodenburg, RJ; Smeitink, JA; Valsecchi, F; Willems, PH | 1 |
| Carrasco-Pozo, C; Gotteland, M; Mizgier, ML; Speisky, H | 1 |
| Bian, HN; Brunk, UT; Song, R; Wang, X; Zhao, KS; Zhao, M | 1 |
| Akude, E; Calcutt, NA; Fernyhough, P; Gomes, S; Marquez, A; Morrow, D; Roy Chowdhury, SK; Saleh, A; Schapansky, J; Smith, DR | 1 |
5 review(s) available for resveratrol and Mitochondrial Diseases
| Article | Year |
|---|---|
Dietary Polyphenols and Mitochondrial Function: Role in Health and Disease.
Topics: Animals; Catechin; Curcumin; Humans; Mitochondria; Mitochondrial Diseases; Oxidative Stress; Quercetin; Resveratrol | 2019 |
A Critical Assessment of the Therapeutic Potential of Resveratrol Supplements for Treating Mitochondrial Disorders.
Topics: Adenosine Triphosphate; Apoptosis; Dietary Supplements; Humans; Mitochondria; Mitochondrial Diseases; Oxidative Phosphorylation; Reactive Oxygen Species; Resveratrol; Stilbenes | 2017 |
Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Bezafibrate; Disease Models, Animal; Energy Metabolism; Mitochondria; Mitochondrial Diseases; Mitochondrial Turnover; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Ribonucleotides; Sirtuin 1; Stilbenes; Transcription Factors; Up-Regulation | 2014 |
Cellular mechanisms of cardioprotection by calorie restriction: state of the science and future perspectives.
Topics: Aged; Animals; Antioxidants; Apoptosis; Autophagy; Caloric Restriction; Cardiovascular Diseases; Disease Models, Animal; Forecasting; Heart Diseases; Homeostasis; Humans; Inflammation; Inflammation Mediators; Mitochondria, Heart; Mitochondrial Diseases; Obesity; Oxidation-Reduction; Oxidative Stress; Resveratrol; Stilbenes | 2009 |
Complex I disorders: causes, mechanisms, and development of treatment strategies at the cellular level.
Topics: Antioxidants; Child; Child, Preschool; Developmental Disabilities; Disease Progression; Drug Delivery Systems; Electron Transport Complex I; Energy Metabolism; Humans; Infant; Infant, Newborn; Mitochondrial Diseases; Organophosphorus Compounds; Oxidative Phosphorylation; Plastoquinone; Resveratrol; Stilbenes; Ubiquinone | 2010 |
2 trial(s) available for resveratrol and Mitochondrial Diseases
| Article | Year |
|---|---|
No effect of resveratrol on fatty acid oxidation or exercise capacity in patients with fatty acid oxidation disorders: A randomized clinical cross-over trial.
Topics: Acyl-CoA Dehydrogenase, Long-Chain; Carnitine O-Palmitoyltransferase; Congenital Bone Marrow Failure Syndromes; Cross-Over Studies; Exercise Tolerance; Fatty Acids; Humans; Lipid Metabolism, Inborn Errors; Metabolism, Inborn Errors; Mitochondrial Diseases; Muscular Diseases; Oxidation-Reduction; Resveratrol | 2022 |
Comparison of the effects of resveratrol and its derivative pterostilbene on hepatic oxidative stress and mitochondrial dysfunction in piglets challenged with diquat.
Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Diquat; Energy Metabolism; Gene Expression Regulation; Glutathione; Herbicides; Liver; Male; Mitochondrial Diseases; NF-E2-Related Factor 2; Oxidative Stress; Resveratrol; Sirtuin 1; Stilbenes; Superoxides; Swine | 2020 |
9 other study(ies) available for resveratrol and Mitochondrial Diseases
| Article | Year |
|---|---|
Protective effect of resveratrol on rat cardiomyocyte H9C2 cells injured by hypoxia/reoxygenation by regulating mitochondrial autophagy PTEN-induced putative kinase protein 1/Parkinson disease protein 2 signaling pathway.
Topics: Animals; Autophagy; Humans; Hypoxia; Mitochondrial Diseases; Myocytes, Cardiac; Parkinson Disease; Protein Kinases; PTEN Phosphohydrolase; Rats; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Signal Transduction; Ubiquitin-Protein Ligases; Ubiquitins | 2022 |
Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates.
Topics: Action Potentials; Acyl-CoA Dehydrogenase, Long-Chain; Arrhythmias, Cardiac; Cardiac Electrophysiology; Congenital Bone Marrow Failure Syndromes; Epoxy Compounds; Fatty Acids; Humans; Induced Pluripotent Stem Cells; Lipid Metabolism, Inborn Errors; Mitochondria; Mitochondrial Diseases; Muscular Diseases; Myocytes, Cardiac; Oxidation-Reduction; Resveratrol | 2020 |
Resveratrol ameliorates disorders of mitochondrial biogenesis and mitophagy in rats continuously exposed to benzo(a)pyrene from embryonic development through adolescence.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Benzo(a)pyrene; Carcinogens; Embryonic Development; Female; Gene Expression Regulation; Maze Learning; Memory; Mitochondrial Diseases; Mitophagy; Neurons; Organelle Biogenesis; Pregnancy; Rats; Rats, Wistar; Resveratrol; Signal Transduction | 2020 |
Resveratrol ameliorates disorders of mitochondrial biogenesis and dynamics in a rat chronic ocular hypertension model.
Topics: Animals; Antioxidants; Apoptosis; Cell Line, Tumor; Cell Survival; Intraocular Pressure; Male; Mitochondria; Mitochondrial Diseases; Ocular Hypertension; Organelle Biogenesis; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Retina; Stilbenes | 2018 |
Mitochondrial biogenesis: pharmacological approaches.
Topics: Animals; DNA, Mitochondrial; Humans; Metformin; Mitochondria; Mitochondrial Diseases; Resveratrol; Stilbenes | 2014 |
Resveratrol attenuates oxidative stress in mitochondrial Complex I deficiency: Involvement of SIRT3.
Topics: Antioxidants; Cells, Cultured; Electron Transport Complex I; ERRalpha Estrogen-Related Receptor; Estrogen Receptor alpha; Fibroblasts; Gene Expression Regulation; Humans; Mitochondria; Mitochondrial Diseases; Oxidative Stress; Oxygen Consumption; Reactive Oxygen Species; Receptors, Estrogen; Resveratrol; Signal Transduction; Sirtuin 3; Stilbenes; Superoxide Dismutase | 2016 |
Differential protective effects of quercetin, resveratrol, rutin and epigallocatechin gallate against mitochondrial dysfunction induced by indomethacin in Caco-2 cells.
Topics: Adenosine Triphosphate; Caco-2 Cells; Catechin; Drug Interactions; Electron Transport Complex I; Gastrointestinal Diseases; Humans; Indomethacin; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Diseases; Quercetin; Resveratrol; Rutin; Stilbenes; Superoxides | 2012 |
Polydatin, a natural polyphenol, protects arterial smooth muscle cells against mitochondrial dysfunction and lysosomal destabilization following hemorrhagic shock.
Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Cyclosporine; Cytoprotection; Glucosides; KATP Channels; Lysosomes; Membrane Potential, Mitochondrial; Mitochondria, Muscle; Mitochondrial Diseases; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocytes, Smooth Muscle; Norepinephrine; Rats; Resveratrol; Shock, Hemorrhagic; Stilbenes | 2012 |
Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Body Weight; Cells, Cultured; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Ganglia, Spinal; Gene Expression Regulation; Green Fluorescent Proteins; Hyperalgesia; Male; Membrane Potentials; Mice; Mitochondrial Diseases; Mitochondrial Membranes; Mutation; Nerve Fibers, Myelinated; Neurites; Oxygen Consumption; Patch-Clamp Techniques; Peripheral Nervous System Diseases; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Physical Stimulation; Rats; Rats, Sprague-Dawley; Reaction Time; Resveratrol; RNA-Binding Proteins; Sensory Receptor Cells; Signal Transduction; Stilbenes; Transcription Factors; Transduction, Genetic | 2012 |